<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: Meet Ian Read&#8217;s New Pharma Team At Pfizer</title>
	<atom:link href="http://www.pharmalot.com/2008/10/meet-ian-reads-new-pharma-team-at-pfizer/feed" rel="self" type="application/rss+xml" />
	<link>http://www.pharmalot.com/2008/10/meet-ian-reads-new-pharma-team-at-pfizer/</link>
	<description>News, Comment and Conversation</description>
	<pubDate>Mon, 15 Mar 2010 15:23:59 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.2</generator>
		<item>
		<title>By: hillary</title>
		<link>http://www.pharmalot.com/2008/10/meet-ian-reads-new-pharma-team-at-pfizer/#comment-442433</link>
		<dc:creator>hillary</dc:creator>
		<pubDate>Thu, 29 Oct 2009 20:45:09 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=17120#comment-442433</guid>
		<description>They are all a bunch of jokers!!</description>
		<content:encoded><![CDATA[<p>They are all a bunch of jokers!!</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Been There</title>
		<link>http://www.pharmalot.com/2008/10/meet-ian-reads-new-pharma-team-at-pfizer/#comment-380799</link>
		<dc:creator>Been There</dc:creator>
		<pubDate>Sat, 08 Nov 2008 07:26:03 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=17120#comment-380799</guid>
		<description>I'm sure that the reference to "Ian's Possee" has nothing to do with their past but rather their relatively recent history.  Their roots are immaterial to the point that was made by the author.

Anyone who truly knows Mohand Sidi Said not only knows the results that he acheived but also how they were achieved.  Shame on Pfizer and its Board of Directors.</description>
		<content:encoded><![CDATA[<p>I&#8217;m sure that the reference to &#8220;Ian&#8217;s Possee&#8221; has nothing to do with their past but rather their relatively recent history.  Their roots are immaterial to the point that was made by the author.</p>
<p>Anyone who truly knows Mohand Sidi Said not only knows the results that he acheived but also how they were achieved.  Shame on Pfizer and its Board of Directors.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Michael Hubert</title>
		<link>http://www.pharmalot.com/2008/10/meet-ian-reads-new-pharma-team-at-pfizer/#comment-380679</link>
		<dc:creator>Michael Hubert</dc:creator>
		<pubDate>Fri, 07 Nov 2008 03:25:48 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=17120#comment-380679</guid>
		<description>Reorganization for reorganization’s sake can create more disruption than value, but what’s different about this one?  It places clear accountability for different parts of the company’s vast business under specific individuals.  For the first time in many years, they have accountability and authority over their businesses—the results will speak for themselves. Would it be possible to withhold judgment until we see how these new leaders and their teams actually perform? 

To call these leaders “Ian’s posse,” by the way, is hard to support with facts.  Olivier Brandicourt came from Warner-Lambert and was hired at Pfizer by Mohand Sidi-Said, one of the Pfizer leaders who produced the great results in the 90s that PYL refers to.  Pedro Lichtinger came from SmithKline’s animal health business and never worked in human pharmaceuticals until Jeff and Ian brought him into that business two years ago.  Dave Simmons used to be in the steel industry before producing an outstanding record in Pfizer’s international business. Jean-Michel Halfon originally joined Pfizer 30 years ago but left and worked for Merck before returning to Pfizer years later.  And Garry Nicholson just joined Pfizer from Eli Lilly earlier this year.

Lastly, it seems PYL has missed the fact that our Worldwide Research and Biotherapeutics and Bioinnovation Center remain wholly independent of our commercial organization.  It is only after these research organizations have produced a compound proven to work in early stage development that the decision to invest hundreds of millions of dollars in late-stage trials shifts to business unit leaders.  These leaders will have to live with the results of those decisions once the compound reaches the market.  This shift means that the people responsible for deciding how much to invest in expensive late-stage trials also have the responsibility for selling the products those trials produce - medicines that patients need.  I would suggest those new medicines, and the patients that they help, be the measure by which we are evaluated.

Michael Hubert
Pfizer</description>
		<content:encoded><![CDATA[<p>Reorganization for reorganization’s sake can create more disruption than value, but what’s different about this one?  It places clear accountability for different parts of the company’s vast business under specific individuals.  For the first time in many years, they have accountability and authority over their businesses—the results will speak for themselves. Would it be possible to withhold judgment until we see how these new leaders and their teams actually perform? </p>
<p>To call these leaders “Ian’s posse,” by the way, is hard to support with facts.  Olivier Brandicourt came from Warner-Lambert and was hired at Pfizer by Mohand Sidi-Said, one of the Pfizer leaders who produced the great results in the 90s that PYL refers to.  Pedro Lichtinger came from SmithKline’s animal health business and never worked in human pharmaceuticals until Jeff and Ian brought him into that business two years ago.  Dave Simmons used to be in the steel industry before producing an outstanding record in Pfizer’s international business. Jean-Michel Halfon originally joined Pfizer 30 years ago but left and worked for Merck before returning to Pfizer years later.  And Garry Nicholson just joined Pfizer from Eli Lilly earlier this year.</p>
<p>Lastly, it seems PYL has missed the fact that our Worldwide Research and Biotherapeutics and Bioinnovation Center remain wholly independent of our commercial organization.  It is only after these research organizations have produced a compound proven to work in early stage development that the decision to invest hundreds of millions of dollars in late-stage trials shifts to business unit leaders.  These leaders will have to live with the results of those decisions once the compound reaches the market.  This shift means that the people responsible for deciding how much to invest in expensive late-stage trials also have the responsibility for selling the products those trials produce - medicines that patients need.  I would suggest those new medicines, and the patients that they help, be the measure by which we are evaluated.</p>
<p>Michael Hubert<br />
Pfizer</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Been There</title>
		<link>http://www.pharmalot.com/2008/10/meet-ian-reads-new-pharma-team-at-pfizer/#comment-380614</link>
		<dc:creator>Been There</dc:creator>
		<pubDate>Thu, 06 Nov 2008 17:38:06 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=17120#comment-380614</guid>
		<description>"Grudge" is right.  

When he led Eastern Eurpope for Pfizer (Human), Alaix came as close as anybody has to being fired for not carefully hiding Pfizer's illegal and unethical business practices, including multiple violations of the Foreign Corrupt Practices Act.  A Read sidekick, he was hidden away in Animal Health where such practices are more accepted and don't often involve foreign government officials.  

Brandicourt talks a good game when Read is not present, leading observers to believe that he is ethical, however he is yet another person in Ian's presence.  Survival, I guess.  

Halfon is a dull bulb, a lap dog.  That is the best I can say about him.  

Henninger and Hill, representing Finance and Human Resources, are keepers of Ian's secrets.  They will stop at nothing to protect him and are summarily rewarded.  I don't know the whole story but I have it on good authority that they worked to support Hank McKinnell, Quentin Heim, Ben Valentini, Bob Brown, Jeff Kindler, Dudley Schleier, and others to bury part of of the Pfizer Japan leadership team for following senior management direction to bring that operation into legal (U.S. and Japan) compliance.  I've heard that McKinnell was confident that they could continue as they had and didn't want to risk losing business by reducing bribes and kickbacks, the natural course of business.  I don't know the individuals involved personally but I'm told that they were paid off and signed contracts not to disclose the facts. Shameful.  The SEC and/or the Justice Department should investigate.  

Some of the rest are the best of a sorry lot; others are good (e.g., Olsen, Simmons) and just hanging on too long.  I don't know Nicholson; I assume that he joined the company relatively recently without full information.</description>
		<content:encoded><![CDATA[<p>&#8220;Grudge&#8221; is right.  </p>
<p>When he led Eastern Eurpope for Pfizer (Human), Alaix came as close as anybody has to being fired for not carefully hiding Pfizer&#8217;s illegal and unethical business practices, including multiple violations of the Foreign Corrupt Practices Act.  A Read sidekick, he was hidden away in Animal Health where such practices are more accepted and don&#8217;t often involve foreign government officials.  </p>
<p>Brandicourt talks a good game when Read is not present, leading observers to believe that he is ethical, however he is yet another person in Ian&#8217;s presence.  Survival, I guess.  </p>
<p>Halfon is a dull bulb, a lap dog.  That is the best I can say about him.  </p>
<p>Henninger and Hill, representing Finance and Human Resources, are keepers of Ian&#8217;s secrets.  They will stop at nothing to protect him and are summarily rewarded.  I don&#8217;t know the whole story but I have it on good authority that they worked to support Hank McKinnell, Quentin Heim, Ben Valentini, Bob Brown, Jeff Kindler, Dudley Schleier, and others to bury part of of the Pfizer Japan leadership team for following senior management direction to bring that operation into legal (U.S. and Japan) compliance.  I&#8217;ve heard that McKinnell was confident that they could continue as they had and didn&#8217;t want to risk losing business by reducing bribes and kickbacks, the natural course of business.  I don&#8217;t know the individuals involved personally but I&#8217;m told that they were paid off and signed contracts not to disclose the facts. Shameful.  The SEC and/or the Justice Department should investigate.  </p>
<p>Some of the rest are the best of a sorry lot; others are good (e.g., Olsen, Simmons) and just hanging on too long.  I don&#8217;t know Nicholson; I assume that he joined the company relatively recently without full information.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Ex-Pfizer with a grudge</title>
		<link>http://www.pharmalot.com/2008/10/meet-ian-reads-new-pharma-team-at-pfizer/#comment-380427</link>
		<dc:creator>Ex-Pfizer with a grudge</dc:creator>
		<pubDate>Tue, 04 Nov 2008 21:29:27 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=17120#comment-380427</guid>
		<description>They are all idiots.  How is that for a summary!  Some have talent like Simmons and Olson, but if they stay at the company and participate in the illegal activities and unethical practices, not to speak of the mismanagement by Read and his crew then they are equally at fault for the demise of a once great company.   

Peck by the way is the biggest joke of all.  Totally over her head!</description>
		<content:encoded><![CDATA[<p>They are all idiots.  How is that for a summary!  Some have talent like Simmons and Olson, but if they stay at the company and participate in the illegal activities and unethical practices, not to speak of the mismanagement by Read and his crew then they are equally at fault for the demise of a once great company.   </p>
<p>Peck by the way is the biggest joke of all.  Totally over her head!</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Christopher</title>
		<link>http://www.pharmalot.com/2008/10/meet-ian-reads-new-pharma-team-at-pfizer/#comment-380319</link>
		<dc:creator>Christopher</dc:creator>
		<pubDate>Tue, 04 Nov 2008 02:14:51 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=17120#comment-380319</guid>
		<description>Dear Jim Smith/Spartacus/Harpy:
So I am naive and you are thick. That's something I can live with and learn from. Remember Sir Winston Churchill and Bessie Braddock, then a fiery socialist who opposed his views?

Bessie Braddock: "Sir, you are drunk."
Churchill: Madam, you are ugly. But in the morning I shall be sober."

Anyway, I think we've made our points.</description>
		<content:encoded><![CDATA[<p>Dear Jim Smith/Spartacus/Harpy:<br />
So I am naive and you are thick. That&#8217;s something I can live with and learn from. Remember Sir Winston Churchill and Bessie Braddock, then a fiery socialist who opposed his views?</p>
<p>Bessie Braddock: &#8220;Sir, you are drunk.&#8221;<br />
Churchill: Madam, you are ugly. But in the morning I shall be sober.&#8221;</p>
<p>Anyway, I think we&#8217;ve made our points.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Doug</title>
		<link>http://www.pharmalot.com/2008/10/meet-ian-reads-new-pharma-team-at-pfizer/#comment-380314</link>
		<dc:creator>Doug</dc:creator>
		<pubDate>Tue, 04 Nov 2008 01:18:18 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=17120#comment-380314</guid>
		<description>Oh, dear Judy, cannot you accept that it was your time to have a heart attack?  It's either because of your lifestyle or your genes... why is that so hard to understand?  Will you feel the same way after you have a stroke, having been on blood pressure medication for the last seven years?  And why would you want someone else to experience the pain you supposedly feel?  That's not very kind.</description>
		<content:encoded><![CDATA[<p>Oh, dear Judy, cannot you accept that it was your time to have a heart attack?  It&#8217;s either because of your lifestyle or your genes&#8230; why is that so hard to understand?  Will you feel the same way after you have a stroke, having been on blood pressure medication for the last seven years?  And why would you want someone else to experience the pain you supposedly feel?  That&#8217;s not very kind.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Ger</title>
		<link>http://www.pharmalot.com/2008/10/meet-ian-reads-new-pharma-team-at-pfizer/#comment-380261</link>
		<dc:creator>Ger</dc:creator>
		<pubDate>Mon, 03 Nov 2008 17:44:14 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=17120#comment-380261</guid>
		<description>PYL, Plead the Pfiz amendment!</description>
		<content:encoded><![CDATA[<p>PYL, Plead the Pfiz amendment!</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Jim Smith</title>
		<link>http://www.pharmalot.com/2008/10/meet-ian-reads-new-pharma-team-at-pfizer/#comment-380222</link>
		<dc:creator>Jim Smith</dc:creator>
		<pubDate>Mon, 03 Nov 2008 15:15:30 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=17120#comment-380222</guid>
		<description>And you're naive to think that just because someone signs with a traditional first name, last name that it's real - or that Ed could do anything to enforce such a policy.</description>
		<content:encoded><![CDATA[<p>And you&#8217;re naive to think that just because someone signs with a traditional first name, last name that it&#8217;s real - or that Ed could do anything to enforce such a policy.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Bob</title>
		<link>http://www.pharmalot.com/2008/10/meet-ian-reads-new-pharma-team-at-pfizer/#comment-380171</link>
		<dc:creator>Bob</dc:creator>
		<pubDate>Mon, 03 Nov 2008 07:27:22 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=17120#comment-380171</guid>
		<description>Replace 'Ian Read' with 'Dick Clark' and 'Our Path Forward' with 'Plan to Win' and you have the same rhetoric that comes out of the Merck announcements. Big Pharma all want to outperform the competitor but they just cannot stop copying each other. Just years of habit I suppose.....</description>
		<content:encoded><![CDATA[<p>Replace &#8216;Ian Read&#8217; with &#8216;Dick Clark&#8217; and &#8216;Our Path Forward&#8217; with &#8216;Plan to Win&#8217; and you have the same rhetoric that comes out of the Merck announcements. Big Pharma all want to outperform the competitor but they just cannot stop copying each other. Just years of habit I suppose&#8230;..</p>
]]></content:encoded>
	</item>
</channel>
</rss>
